Posted by jane d on October 10, 2002, at 23:28:50
In reply to Re: AD's vs. Bzds for Anxiety disorders » pharmrep, posted by Alan on October 10, 2002, at 22:31:14
> Would you please elaborate further about the need to focus on AD's at the expense of Bzd's in the treatment of anxiety disorders....causing doctors to mistakenly offer only AD monotherapy instead of both BZD monotherapy AND AD monotherapy on equal footing for their patients' clinical trials?
>Alan,
Pharmrep has said he is a sales representative for a company, not a representative of the industry as a whole. It's not reasonable to expect him to be able to answer questions about overall drug development or marketing policies. Probably you and the other posters on this board that have a personal interest in bzds know as much as anybody else.
Jane
poster:jane d
thread:109458
URL: http://www.dr-bob.org/babble/20021006/msgs/123162.html